Salvia Cosmeceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 02-07-2024
- Paid Up Capital ₹ 0.10 M
as on 02-07-2024
- Company Age 14 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 50.74%
(FY 2023)
- Profit 60.47%
(FY 2023)
- Ebitda -58.78%
(FY 2023)
- Net Worth 47.48%
(FY 2023)
- Total Assets -9.40%
(FY 2023)
About Salvia Cosmeceuticals
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Archana Kakar and Ajay Kakar serve as directors at the Company.
- CIN/LLPIN
U24100DL2010PTC206329
- Company No.
206329
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jul 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Salvia Cosmeceuticals Private Limited offer?
Salvia Cosmeceuticals Private Limited offers a wide range of products and services, including Ayurvedic, Herbal Oils and Cosmetics, Aloe Vera Cosmetics, Hand Sanitizers & Personal Hygiene, Herbal Soaps, Herbal Skin Care Cosmetics, Cosmetics, Hair & Beauty Products, Face Cream, Body Care Products, Nutraceuticals & Dietary Supplements, Weight Loss Supplement.
Who are the key members and board of directors at Salvia Cosmeceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Archana Kakar  | Director | 27-Jul-2010 | Current |
| Ajay Kakar | Director | 27-Jul-2010 | Current |
Financial Performance of Salvia Cosmeceuticals.
Salvia Cosmeceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 50.74% increase. The company also saw a substantial improvement in profitability, with a 60.47% increase in profit. The company's net worth Soared by an impressive increase of 47.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Salvia Cosmeceuticals?
In 2023, Salvia Cosmeceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Salve Pharmaceuticals Private LimitedActive 18 years 10 monthsArchana Kakar and Ajay Kakar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Salvia Cosmeceuticals?
Unlock and access historical data on people associated with Salvia Cosmeceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Salvia Cosmeceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Salvia Cosmeceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
